Clinical trials
Lung Diseases clinical trials
Below are recruiting lung diseases clinical trials, each written for real people, not researchers. We’re tracking 424 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05854563Recruiting
Study using collected cough samples to learn about lung disease
This trial looks at “cough capture” samples to better understand what is happening in the lungs. You might be eligible if you’re having a bronchoscopy for medical reasons and don’t already have lung cancer.
The Bronx, New YorkAges 21 years+ - NCT05835271Enrolling by invitation
Hip exoskeleton to help walking in severe lung disease
This trial tests a powered hip exoskeleton device to improve walking ability in people with stable, severe lung-related breathing problems. It may help you walk farther or more comfortably by supporting your movement, as long as your heart, blood pressure, and skin/body fit are safe for the device.
Toronto, OntarioAges 18 years+ - NCT05365009Recruiting
Autoimmune lung scarring registry for adults with recent diagnosis
This registry collects health and breathing test information from adults with autoimmune-related lung scarring (interstitial lung disease) diagnosed recently. It helps researchers better understand who has this condition and how it changes over time.
Buenos AiresAges 18 years+ - NCT04707781Recruiting
Database study for people at risk of lung scarring
This trial is a study database that collects information from adults who have other illnesses that can increase the risk of developing interstitial lung disease (lung scarring). It may help researchers better understand who is at risk and how outcomes change over time.
GrazAges 18 years+ - NCT07723872Recruiting
Finger vs. earlobe oxygen test during a 6-minute walk
This study compares oxygen levels measured at the finger versus the earlobe during a 6-minute walk test for people with interstitial lung disease. It helps find the most accurate way to monitor your oxygen during exercise.
Granollers, SpainAges 18 years+ - NCT04095351Recruiting
Study of connective tissue disease affecting the lungs
This study looks at people aged 18 and older who have a connective tissue disease and lung involvement. It aims to better understand how these lung problems progress and may help doctors choose better care.
InnsbruckAges 18–80 - NCT03561818Recruiting
Home or hospital physiotherapy for bronchiectasis efficiency
This study compares how well breathing/airway physiotherapy works when done at home versus in a hospital for people with bronchiectasis. It may help determine which approach is easier and works best while you’re stable.
Istanbul, ZeytinburnuAges 18–75 - NCT07486869RecruitingPhase 2
Emapalumab study for MDA5-related lung disease
This trial tests if emapalumab can help people with a serious lung condition linked to MDA5 antibodies. It may be an option for those with worsening breathing despite other treatments.
Miami, FloridaAges 18 years+ - NCT07790614Recruiting
Comparing two CT scan methods for identifying pulmonary fibrosis
This study compares two types of CT scans to see which one is better at identifying idiopathic pulmonary fibrosis (IPF), a specific type of interstitial lung disease. You may be able to join if you have been diagnosed with ILD and are being discussed by a team of specialists.
Rozzano, ItalyAges 18 years+ - NCT07597187Recruiting
Analyzing lung tissue samples to improve chronic lung disease diagnosis
This study uses a new imaging technology called LIBS to examine lung tissue samples that were already removed as part of your regular care. The goal is to see if this method can help doctors better understand and diagnose chronic lung diseases like interstitial lung disease, sarcoidosis, or emphysema.
GrenobleAges 18 years+ - NCT07540988RecruitingPhase 3
Testing Nerandomilast for Scarring Lung Disease
This study tests whether a new drug called nerandomilast can slow down scarring in the lungs for people with certain types of fibrosing interstitial lung disease (a condition where lung tissue becomes thick and scarred). You may qualify if you have lung scarring that is getting worse and haven't tried this or similar drugs before.
Birmingham, AlabamaAges 18 years+ - NCT07843381Recruiting
Testing a new drug for Sjögren's syndrome with lung disease
This clinical trial tests a new drug called telitacicept for people who have both Sjögren's syndrome and interstitial lung disease. The drug aims to reduce the immune system's attack on your body and may help improve lung symptoms.
BeijingAges 18–70 - NCT07500818Recruiting
Robot vs. standard scope for lung biopsy in ILD
This study compares a robotic-assisted bronchoscope to a conventional one for performing a lung biopsy (cryobiopsy) in people with interstitial lung disease. The goal is to see which method is better at getting enough tissue for a diagnosis.
Lucerne, Canton of LucerneAges Any age - NCT07486206Recruiting
Optimizing follow-up for interstitial lung disease
This trial tests a new way to organize follow-up visits for people with interstitial lung disease (a group of lung conditions). It aims to make care simpler and more effective for patients who are already on treatment.
Granollers, BarcelonaAges 18 years+ - NCT07398287RecruitingPhase 2
Menthol for breathlessness in interstitial lung disease
This study tests if inhaling L-menthol can help reduce breathlessness in people with interstitial lung disease. You will cycle while breathing menthol or a placebo to see if it makes breathing easier.
Karlskrona, Blekinge CountyAges 18 years+ - NCT05417776RecruitingPhase 2
PET scan test for early lung scarring
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
Boston, MassachusettsAges 40 years+ - NCT03800017Recruiting
Muscle strength and exercise function in lung scarring
This study looks at how well skeletal (muscle) function supports exercise in people with interstitial lung diseases (including idiopathic pulmonary fibrosis). It may help better understand fitness and breathing limits, which can guide rehabilitation choices and future care.
Vancouver, British ColumbiaAges 40–80 - NCT04299945Recruiting
Beetroot juice to boost exercise in fibrotic lung disease
This trial tests whether drinking beetroot juice can improve exercise performance in people with fibrotic interstitial lung disease (scarring in the lungs). It may help your body use oxygen better during activity if you meet the study’s safety and lung-function requirements.
Vancouver, British ColumbiaAges 19 years+ - NCT06988943Recruiting
Finding lung cancer early with CT screening in Guangzhou communities
This study is testing a way to find lung cancer early by offering free CT scans to people in certain communities in Guangzhou. It helps catch cancer before symptoms start.
Guangzhou, GuangdongAges 40–74 - NCT06992661RecruitingPhase 1
Inhaled RJ026 study for interstitial lung disease patients
This trial tests a single inhaled dose of RJ026 in patients with interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF) or connective tissue disease-related ILD (CTD-ILD). It helps see how the drug moves through the body and if it's safe.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT06948916Recruiting
Test of a 6-minute pegboard and ring exercise in ILD
This study will test a simple exercise test that uses a pegboard and rings to measure how your lungs and body work together. It may help doctors better understand your breathing ability.
AnkaraAges 18–75 - NCT06948942Recruiting
Exercise ability in interstitial lung disease
This study compares exercise capacity, muscle oxygen levels, and physical activity between people with interstitial lung disease (ILD) and healthy volunteers. It aims to understand how ILD affects daily movement and overall fitness.
AnkaraAges 18–75 - NCT07615504Recruiting
Better diagnostic testing for interstitial lung disease
This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.
BlackpoolAges 18–90 - NCT06645977Recruiting
Study for patients with interstitial lung disease
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
Rome, RMAges 18 years+
Hear when a new Lung Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lung diseases?
- Yes. Clin2 currently lists 424 recruiting lung diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lung diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lung diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.